Globus Medical to Acquire NuVasive for $3.1 Billion

Globus Medical announced that it would acquire NuVasive via an all-stock transaction valued at $3.1 billion. The move combines the No. 7 and No. 8 players by revenue in the orthopedic industry, and has implications to significantly transform the spine market.

The transaction is expected to close in mid-2023.
Agreement Terms

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us